Silence Therapeutics | SLN - Ebit

Prix De L'Action
4.93
Variation Quotidienne
-0.38 -7.16%
Mensuellement
-17.56%
Annuel
43.31%
Q1 Prévisions
5.35




Ebit Changement Date
AstraZeneca USD 2.97B 4.48B 2025-12
Autolus Therapeutics Ltd USD -72.47M 845K 2025-12
Hikma Pharmaceutical USD 348M 31M 2025-12
Novartis USD 4.06B 530M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Silence Therapeutics USD -12.46M 13.78M 2025-12